March 05, 2015 7:34 PM ET


Company Overview of Adamas Pharmaceuticals, Inc.

Key Executives for Adamas Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gregory T. Went Ph.D.33 RelationshipsChairman and Chief Executive Officer50
William J. Dawson 6 RelationshipsChief Financial Officer59
Jeffrey H. Knapp No RelationshipsChief Operating Officer and Chief Commercial Officer48
David N. Chernoff M.D.49 RelationshipsActing Chief Medical Officer--
Natalie L. McClure Ph.D.No RelationshipsSenior Vice President of Product Development61

Adamas Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gregory T. Went Ph.D. 33 RelationshipsAdamas Pharmaceuticals, Inc.50
David L. Mahoney 47 RelationshipsAdamas Pharmaceuticals, Inc.60
Richard H. Booth CPA, CLU, ChFC 107 Relationships1347 Capital Corp.67
Martha J. Demski 54 RelationshipsAjinomoto Althea, Inc.61
William W. Ericson J.D. 147 RelationshipsMohr Davidow Ventures55
View All Board Members

Adamas Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Martha J. Demski54 Relationships3 Executives
Compensation Committee CPA, CLU, ChFCRichard H. Booth107 Relationships3 Executives
Nominating Committee David L. Mahoney47 Relationships3 Executives
Corporate Governance Committee David L. Mahoney47 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$728.0K
Compensation as of Fiscal Year 2013
Adamas Pharmaceuticals, Inc. CEO Compensation
Industry Average


Eveready Industries India Limited Announces P H Ravikumar Ceased to Be Independent Director
March 02, 2015 9:29 AM ET
SCA Announces Executive Changes
March 02, 2015 7:07 AM ET
SCA Appoints Linda Nyberg as Vice President of Media Relations and Online Communications
February 26, 2015 12:00 AM ET
Hipolin Limited Announces Management Appointments
February 23, 2015 10:19 AM ET
Harbinger Group Inc. Appoints Curtis Glovier as Class II Director
February 20, 2015 10:05 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adamas Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at